Hsu E, Keene D, Ventureyra E, Matzinger M A, Jimenez C, Wang H S, Grimard L
Pediatric Neuro-oncology Service, Children's Hospital of Eastern Ontario, Canada.
J Neurooncol. 1998 May;37(3):285-93. doi: 10.1023/a:1005909127196.
With the increasing survival time of many pediatric patients with malignancies, unexpected symptoms or signs require diligent search for rare complications or second cancers related to the disease or treatment. We recently encountered a patient with extensive glioblastoma multiforme who developed pancytopenia six months after completion of treatment with craniospinal radiation and chemotherapy with etoposide and cyclophosphamide. Bone marrow aspirate and biopsy confirmed bone marrow metastasis from the brain tumor. He showed good partial remission with chemotherapy with carmustine and cis-platinum as demonstrated by serial bone marrow aspirate for cytology and cytogenetics and enjoyed good quality of life for eight months. 14 other patients with astrocytic glioma, two of whom are children, are reported in the literature to have diffuse bone marrow metastasis. Therefore, in patients with malignant astrocytic tumor, bone marrow metastasis, though not common, should be considered when bone pain or cytopenias occur, especially when prolonged.
随着许多小儿恶性肿瘤患者生存时间的延长,出现的意外症状或体征需要我们认真排查与疾病或治疗相关的罕见并发症或二次癌症。我们最近遇到一名患有广泛多形性胶质母细胞瘤的患者,在完成颅脊髓放疗以及依托泊苷和环磷酰胺化疗六个月后出现全血细胞减少。骨髓穿刺和活检证实为脑肿瘤骨髓转移。他接受卡莫司汀和顺铂化疗后显示出良好的部分缓解,连续骨髓穿刺进行细胞学和细胞遗传学检查证明了这一点,并且八个月来生活质量良好。文献报道了另外14例星形细胞瘤患者发生弥漫性骨髓转移,其中两例为儿童。因此,对于恶性星形细胞瘤患者,当出现骨痛或血细胞减少,尤其是持续性的骨痛或血细胞减少时,应考虑骨髓转移,尽管这种情况并不常见。